USPTO 2015–2025 USPTO PatentsView US Corporation

Seven Bridges Genomics Inc.

USPTO PatentsView assignee record - 65 granted patents across 11 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G16B (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

18.6

Avg claims per patent

+110%

5-year filing velocity

The verdict

Seven holds 65 US patents across 11 technology areas, rank #5,320 of 50,000 tracked assignees.

#5,320
of 50,000 US assignees by volume: Top 31%
by Innovation Score (42.2/100): 18.6
avg claims per patent: +110%
filing velocity, last 5 yrs

Portfolio overview

Seven Bridges Genomics Inc. has been granted 65 US utility patents between 2015 and 2025, placing Seven Bridges Genomics Inc. at rank #5,320 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.6 claims per patent with primary concentration in G16B (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY). As a US Corporation, Seven Bridges Genomics Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Seven sits between SDS Asia Limited, BVI #1748971 (65 patents, rank #5,316) and Subsea 7 Limited (65 patents, rank #5,324) - the closest US assignees by grant volume. The composite Innovation Score of 42.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 44 grants, compared with 21 in the 2015–2019 window, a +110% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Seven Bridges Genomics Inc.'s 18.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Seven Bridges Genomics Inc. against peers pursuing similar technology classes.

SDS Asia BVI #174…

65
Seikagaku

65
SPR Therapeutics

65
Schneider Toshiba…

65
Shenzhen Grandsun

65
Shock Doctor

65
Sonic IP

65
Subsea 7

65
Seven Bridges Gen… ◀

65

What this shows Seven holds 65 patents at rank #5,320, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Seven

By rank, the assignees closest to #5,320 in granted patent volume.

Leaders in G16B (Bioinformatics)

Other assignees with the most granted patents in Seven's primary technology class.

Seven's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

42 Top 31% higher than 69% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Seven Bridges Genomics Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	4.6%
2016	1	1.5%
2017	2	3.1%
2018	6	9.2%
2019	9	13.8%
2020	13	20.0%
2021	7	10.8%
2022	8	12.3%
2023	8	12.3%
2024	5	7.7%
2025	3	4.6%

Which technologies does Seven Bridges Genomics Inc. patent most?

G16B - BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY 60

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 21

G06F - ELECTRIC DIGITAL DATA PROCESSING 17

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 6

H04L - TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION 5

H03M - CODING; DECODING; CODE CONVERSION IN GENERAL 3

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 2

G06V - IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING 2

G06Q - INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR 2

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 2

G16C - COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE 1

Top 11 of 11 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Accelerating

Where it ranks

Overall rank by patents

#5,320

Across all tracked assignees

Innovation Score

42.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Seven Bridges Genomics Inc. hold?

Seven Bridges Genomics Inc. holds 65 US granted patents filed between 2015 and 2025, spanning 11 technology areas.

What is Seven Bridges Genomics Inc.'s Innovation Score?

Seven Bridges Genomics Inc. has an Innovation Score of 42.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Seven Bridges Genomics Inc. focus on?

Seven Bridges Genomics Inc.'s top technology area is G16B (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY) with 60 patents. The company has filed patents in 11 CPC subclasses total.

Is Seven Bridges Genomics Inc.'s patent filing rate increasing or decreasing?

Seven Bridges Genomics Inc.'s recent filing velocity is +110% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Seven Bridges Genomics Inc.'s patents?

Seven Bridges Genomics Inc.'s patents average 18.6 claims each. This falls within the standard range, providing solid legal coverage.

How is the Seven Bridges Genomics Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Seven's 65 grants land it in the top 31% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Seven ranks #5,320 of 50,000. Top 50 holders
Most of this portfolio concentrates in G16B - see who else leads that technology area. G16B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.